[go: up one dir, main page]

UA83012C2 - Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты - Google Patents

Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты

Info

Publication number
UA83012C2
UA83012C2 UAA200504948A UA2005004948A UA83012C2 UA 83012 C2 UA83012 C2 UA 83012C2 UA A200504948 A UAA200504948 A UA A200504948A UA 2005004948 A UA2005004948 A UA 2005004948A UA 83012 C2 UA83012 C2 UA 83012C2
Authority
UA
Ukraine
Prior art keywords
hydroxyethylidene
pyridyl
sodium salt
bisphosphonic acid
weight
Prior art date
Application number
UAA200504948A
Other languages
English (en)
Ukrainian (uk)
Inventor
Индрих Рихтер
Йосеф Ирман
Original Assignee
ЗЕНТИВА, а.с.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЗЕНТИВА, а.с. filed Critical ЗЕНТИВА, а.с.
Publication of UA83012C2 publication Critical patent/UA83012C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
UAA200504948A 2002-10-25 2003-10-21 Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты UA83012C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20023574A CZ293349B6 (cs) 2002-10-25 2002-10-25 Nová krystalická forma sodné soli kyseliny 3-pyridyl-1-hydroxyethyliden-1,1-bisfosfonové

Publications (1)

Publication Number Publication Date
UA83012C2 true UA83012C2 (ru) 2008-06-10

Family

ID=32046706

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200504948A UA83012C2 (ru) 2002-10-25 2003-10-21 Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты

Country Status (13)

Country Link
US (1) US7276604B2 (ru)
EP (1) EP1556041B1 (ru)
JP (1) JP2006511489A (ru)
AT (1) ATE371452T1 (ru)
AU (1) AU2003273728A1 (ru)
CA (1) CA2503154C (ru)
CZ (1) CZ293349B6 (ru)
DE (1) DE60316010D1 (ru)
EA (1) EA009036B1 (ru)
PL (1) PL374896A1 (ru)
SK (1) SK50422005A3 (ru)
UA (1) UA83012C2 (ru)
WO (1) WO2004037252A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293349B6 (cs) 2002-10-25 2004-04-14 Léčiva, A.S. Nová krystalická forma sodné soli kyseliny 3-pyridyl-1-hydroxyethyliden-1,1-bisfosfonové
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts
SK50782006A3 (sk) * 2004-02-26 2007-03-01 Zentiva, A. S. Amorfné formy risedronátu monosodného
GB0519891D0 (en) * 2005-09-30 2005-11-09 Pliva Hrvatska D O O Pharmaceutically acceptable salts and hydrates
WO2007042048A2 (en) * 2005-10-11 2007-04-19 Sandoz A/S Method for preparing crystalline sodium risedronate
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
JP2009536639A (ja) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド 純リセドロン酸または塩を調製するための方法
GB0609465D0 (en) * 2006-05-12 2006-06-21 Pliva Hrvatska D O O Pharmaceutically acceptable salts and polymorphic forms
KR100961822B1 (ko) 2006-09-28 2010-06-08 플레밍 레보레이토리스 리미티드 3-피리딜-1-히드록시에틸리딘-1,1-비스포스폰산 나트륨염의순수한 다형체 제조방법
GB0619891D0 (en) * 2006-10-07 2006-11-15 Pliva Istrazivanje I Razvoj D Pharmaceutical composition of risedronate
KR100812528B1 (ko) 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009003001A2 (en) * 2007-06-27 2008-12-31 Dr. Reddy's Laboratories Ltd. Preparation of risedronate sodium hemi-pentahydrate
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese
KR100925835B1 (ko) 2007-12-07 2009-11-06 동우신테크 주식회사 리세드로네이트 나트륨 무수물 및 수화물의 제조방법
CN111631686B (zh) * 2020-05-18 2022-03-15 湖南大学 一种利用核磁共振成像监测胃酸pH值的胶囊及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
PL372964A1 (en) * 2002-04-11 2005-08-08 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium
CZ293349B6 (cs) 2002-10-25 2004-04-14 Léčiva, A.S. Nová krystalická forma sodné soli kyseliny 3-pyridyl-1-hydroxyethyliden-1,1-bisfosfonové

Also Published As

Publication number Publication date
ATE371452T1 (de) 2007-09-15
CA2503154A1 (en) 2004-05-06
US20060148762A1 (en) 2006-07-06
CA2503154C (en) 2009-09-15
EP1556041B1 (en) 2007-08-29
JP2006511489A (ja) 2006-04-06
CZ20023574A3 (en) 2004-04-14
SK50422005A3 (sk) 2005-08-04
EP1556041A1 (en) 2005-07-27
PL374896A1 (en) 2005-11-14
AU2003273728A1 (en) 2004-05-13
DE60316010D1 (de) 2007-10-11
CZ293349B6 (cs) 2004-04-14
WO2004037252A1 (en) 2004-05-06
EA009036B1 (ru) 2007-10-26
EA200500701A1 (ru) 2006-02-24
US7276604B2 (en) 2007-10-02

Similar Documents

Publication Publication Date Title
UA83012C2 (ru) Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты
AU2001276721A1 (en) Salts of benzimidazole compound and use thereof
GB2395946B (en) Method for the production of sodium chloride from seawater
ATE466563T1 (de) Magnesium-substituierte hydroxylapatite
ES8604249A1 (es) Un procedimiento para preparar pseudomonato de calcio cris- talino o un hidrato del mismo
WO2008130472A3 (en) Calcium hypochlorite compositions comprising zinc salts and lime
NZ510070A (en) Crystalline forms of EtO2 C-CH2 -(R)Cgl-Aze-Pab-OH
YU184291A (sh) Postupak za dobijanje stabilne formulacije soli enalaprila
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
PL345021A1 (en) Methods of inhibiting corrosion using isomers of chloro-methylbenzotriazole
PL357469A1 (en) Fertiliser additive comprising magnesium and calcium sulphate and carbonate
YU38401A (sh) Derivati benzofurana, njihova izrada i upotreba
IL141222A0 (en) A process for the preparation of zofenopril calcium salt
GB0319165D0 (en) Improved cleaning composition
DE60328192D1 (de) Kristalline formen von imidoalkanpercarbonsäuren
AU2003272474A1 (en) Improved conversion of sodium bromide to anhydrous hydrobromic acid and sodium bisulfate
RU97108515A (ru) Способ изоляции водопроницаемого пласта
PT1615908E (pt) Sal básico de ácido tióctico com l-carnitina
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
RU2002100452A (ru) Солевое покрытие
HU0005005D0 (ru)
IL152590A0 (en) Treatment of congestive heart failure
ES2154235B1 (es) Procedimiento para la obtencion de fluoruro sodico.
GB0229453D0 (en) Improvements in or related to organic compounds
MD2275F1 (en) Fungicidal composition